Clinical Trials
24
Active:0
Completed:19
Trial Phases
4 Phases
Phase 1:1
Phase 2:9
Phase 3:12
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials
Phase 3
12 (50.0%)Phase 2
9 (37.5%)Phase 4
2 (8.3%)Phase 1
1 (4.2%)Pharmacokinetic Study of Synera in Healthy Volunteers
- First Posted Date
- 2012-05-21
- Last Posted Date
- 2012-10-17
- Lead Sponsor
- ZARS Pharma Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01602757
- Locations
- 🇺🇸
Cetero Research, Fargo, North Dakota, United States
Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy
Phase 2
Completed
- Conditions
- Patellar Tendinopathy
- Interventions
- Drug: Heated Lidocaine and Tetracaine Patch
- First Posted Date
- 2010-04-28
- Last Posted Date
- 2012-03-16
- Lead Sponsor
- ZARS Pharma Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT01111773
- Locations
- 🇺🇸
Sports Medicine Clinic, Warren, Michigan, United States
Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points
Phase 2
Completed
- Conditions
- Myofascial Pain Syndromes
- Interventions
- Drug: Heated lidocaine/tetracaine patch
- First Posted Date
- 2010-04-20
- Last Posted Date
- 2012-03-16
- Lead Sponsor
- ZARS Pharma Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01106989
- Locations
- 🇺🇸
The Center for Clinical Research, Winston-Salem, North Carolina, United States
Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome
Phase 2
Completed
- Conditions
- Shoulder Impingement Syndrome
- Interventions
- Drug: Heated lidocaine and tetracaine topical patch
- First Posted Date
- 2010-01-25
- Last Posted Date
- 2012-03-16
- Lead Sponsor
- ZARS Pharma Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01055444
- Locations
- 🇺🇸
Injury Care Medical Center, Boise, Idaho, United States
Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome
Phase 2
Completed
- Conditions
- Carpal Tunnel Syndrome
- Interventions
- First Posted Date
- 2009-10-07
- Last Posted Date
- 2012-03-16
- Lead Sponsor
- ZARS Pharma Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00991068
- Locations
- 🇺🇸
International Clinical Research Institute, Overland Park, Kansas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found